antibody therapy: Seeks to understand the role of myeloid-derived suppressive cells in resistance to anti-PD-1 therapy MRA Pilot Award, 2017-2020 Brent Hanks, Duke University Medical Center Targeting Foxp3 and NMD blockade in melanoma to unleash tumor immunity: Plans to test the therapeutic potential of